The host responds to lymphopenic environments by acute homeostatic proliferation, which is a cytokine-and endogenous peptide-driven expansion of lymphocytes that restores the numbers and diversity of T cells. It is unknown how these homeostatically proliferating (HP) cells are ultimately controlled. Using a system where lymphocytic choriomeningitis virusimmune C57BL/6 splenocytes were transferred into lymphopenic T cell -defi cient hosts and allowed to reconstitute the environment, we defi ned the following three populations of T cells: slowly dividing Ly6C؉ cells, which contained bona fi de virus-specifi c memory cells, and more rapidly dividing Ly6C − cells segregating into programmed death (PD)-1؉ and PD-1 − fractions. The PD-1؉ HP cell population, which peaked in frequency at day 21, was dysfunctional in that it failed to produce interferon ␥ or tumor necrosis factor ␣ on T cell receptor (TCR) stimulation, had down-regulated expression of interleukin (IL)-7R ␣ , IL-15R ␤ , and Bcl-2, and reacted with Annexin V, which is indicative of a preapoptotic state. The PD-1؉ HP cells, in contrast to other HP cell fractions, displayed highly skewed TCR repertoires, which is indicative of oligoclonal expansion; these skewed repertoires and the PD-1؉ population disappeared by day 70 from the host, presumably because of apoptosis. These results suggest that PD-1 may play a negative regulatory role to control rapidly proliferating and potentially pathogenic autoreactive CD8؉ T cells during homeostatic reconstitution of lymphopenic environments. memory cells underwent relatively limited cell division and were substantially diluted in frequency by other more extensively proliferating cells originating from that donor cell population ( 1 ). This pattern of division is seen in Fig. 1 A , where, 12 d after cell transfer, the viral peptide -specifi c CD8 T cells, as detected by intracellular IFN ␥ assay, were mostly in the CFSE-positive cells that had undergone limited numbers of divisions. We questioned how the slowly dividing population, which contained bona fi de memory cells, diff ered from the rapidly dividing cells, which contained memory-like cells. As a preliminary screen, we performed a comparative genome-wide microarray analysis of genes expressed on sorted, rapidly proliferating (CFSE-low) and slowly proliferating (CFSE-high) CD8 cell populations, as described in Materials and methods. One of the most dramatic diff erences was in PD-1 mRNA levels, which were high in the CFSElow population, but below reliable detection in the CFSEhigh population. In addition, mRNA levels for IL-7R ␣ , IL-15R ␤ , and Bcl-2 were 3 -13-fold lower in the CFSE-low population than in the CFSE-high population. Based on the information obtained from the gene array experiment, we stained HP cells with PD-1 -specifi c antibody 13 d after transfer and confi rmed that this molecule was highly expressed on a large proportion of the CFSE-low population (28.6 Ϯ 7.2%, n ϭ 4), but on only a few cells in the CFSE-high population (1.0 Ϯ 0.3%, n ϭ3; Fig. 1 B ) . Very little (5.8 Ϯ 3.3%, n ϭ3) expression of PD-1 was seen in donor CD8 cells before adoptive transfer or on donor cells that had been transferred into normal C57BL/6 mice, where acute homeostatic proliferation does not occur because of the replete immune system (Fig. 1 B) . We next measured the kinetics of PD-1 expression on CD8ϩ donor cells during reconstitution of the lymphopenic environment. Barely detectable before transfer, PD-1 expression slightly increased at day 7, peaked at day 21, and returned to pretransfer levels by day 70 ( Fig. 1 C ) . As the PD-1ϩ cell frequency declined from day 21 to 70, the total donor cell number only moderately increased ( Fig. 1 D ) , indicating a substantial loss in PD-1ϩ cell number. Expression of PD-1 on CFSE-low donor cells similar to those in Fig.  1 B was also seen in LCMV-immune donor cell populations transferred into B6 mice rendered lymphopenic by 600 Gy irradiation. Fig. 1 E is a representative plot from an experiment where 16 Ϯ 9% ( n ϭ 5) of cells were PD-1+ and CFSE-low, whereas 1.4 Ϯ 0.2% ( n ϭ 5) of cells were PD-1+ CFSE-high, at day 32. Because PD-1 is reported to regulate the expansion of self-reactive autoimmune T cells, we also tested the fate of transgenic HY male antigen-specifi c donor cells in a T cell KO environment ( Fig. 1 F ) . Spleen CD8 T cells from female HY-transgenic mice contain ‫ف‬ 30% of cells expressing both the ␣ and ␤ TCR transgenes, whereas the rest represent a diverse T cell population expressing diff erent TCR ␣ proteins. In this and a second experiment, transferred transgenic HY CD8ϩ T cells dramatically expanded by day 6 in male T cell KO mice (3.8 Ϯ 2 ϫ 10 5 , n ϭ 4) in comparison to those in female KO mice (1.9 Ϯ 1.4 ϫ 10 4 , n ϭ 3) or lymphocyte-replete B6 male mice (2.3 Ϯ 0.89 ϫ 10 4 , n ϭ 4) which peripheral tolerance mechanisms are involved in the regulation of T cells responding to self-or environmental antigens during homeostatic reconstitution.
Naive CD8ϩ T cells proliferate after being adoptively transferred into mice rendered lymphopenic by genetics (T cell knockout [KO] or SCID), irradiation, or cytokine induction by Toll receptor agonists or viral infections ( 1 ) . This acute homeostatic proliferation is a compensatory mechanism to replenish the peripheral T cell pool. It has been estimated that only ‫ف‬ 30% of the naive CD8ϩ T cell population rapidly proliferate under lymphopenic conditions ( 2 ) , perhaps because acute homeostatic proliferation of CD8ϩ T cells occurs by interaction between the TCR and MHC-expressing self-or environmental peptides ( 3, 4 ) . These lymphopenia-driven CD8ϩ T cells have " memory-like " features, including the expression of the activation/memory marker CD44 and the ability to produce IFN ␥ on TCR stimulation ( 5 -7 ) .
Previous studies have demonstrated that those naive CD8ϩ T cells whose TCR have high affi nity to endogenous or self-antigens have an advantage for undergoing acute homeostatic proliferation ( 8 ) . This suggests a potential to skew the TCR repertoire toward oligoclonal expansion, though this is sometimes diffi cult to see because so many T cells proliferate. However, autoreactive T cells have an enhanced ability to initiate autoimmunity during the reconstitution of lymphopenic environments, such as in the nonobese diabetic mouse model ( 9 ) . In humans, T cell lymphopenia has been associated with autoimmune diseases, such as rheumatoid arthritis, systemic lupus erythematosus, and insulindependent diabetes mellitus ( 10 -13 ) . These fi ndings suggest that lymphopenic conditions are potentially hazardous for immune regulation, and imply that some mechanism must regulate these processes to prevent higher incidences of autoimmunity. Thus far, it is unclear memory cells underwent relatively limited cell division and were substantially diluted in frequency by other more extensively proliferating cells originating from that donor cell population ( 1 ) . This pattern of division is seen in Fig. 1 A , where, 12 d after cell transfer, the viral peptide -specifi c CD8 T cells, as detected by intracellular IFN ␥ assay, were mostly in the CFSE-positive cells that had undergone limited numbers of divisions. We questioned how the slowly dividing population, which contained bona fi de memory cells, diff ered from the rapidly dividing cells, which contained memory-like cells. As a preliminary screen, we performed a comparative genome-wide microarray analysis of genes expressed on sorted, rapidly proliferating (CFSE-low) and slowly proliferating (CFSE-high) CD8 cell populations, as described in Materials and methods. One of the most dramatic diff erences was in PD-1 mRNA levels, which were high in the CFSElow population, but below reliable detection in the CFSEhigh population. In addition, mRNA levels for IL-7R ␣ , IL-15R ␤ , and Bcl-2 were 3 -13-fold lower in the CFSE-low population than in the CFSE-high population. Based on the information obtained from the gene array experiment, we stained HP cells with PD-1 -specifi c antibody 13 d after transfer and confi rmed that this molecule was highly expressed on a large proportion of the CFSE-low population (28.6 Ϯ 7.2%, n ϭ 4), but on only a few cells in the CFSE-high population (1.0 Ϯ 0.3%, n ϭ3; Fig. 1 B ) . Very little (5.8 Ϯ 3.3%, n ϭ3) expression of PD-1 was seen in donor CD8 cells before adoptive transfer or on donor cells that had been transferred into normal C57BL/6 mice, where acute homeostatic proliferation does not occur because of the replete immune system (Fig. 1 B) . We next measured the kinetics of PD-1 expression on CD8ϩ donor cells during reconstitution of the lymphopenic environment. Barely detectable before transfer, PD-1 expression slightly increased at day 7, peaked at day 21, and returned to pretransfer levels by day 70 ( Fig. 1 C ) . As the PD-1ϩ cell frequency declined from day 21 to 70, the total donor cell number only moderately increased ( Fig. 1 D ) , indicating a substantial loss in PD-1ϩ cell number. Expression of PD-1 on CFSE-low donor cells similar to those in Fig.  1 B was also seen in LCMV-immune donor cell populations transferred into B6 mice rendered lymphopenic by 600 Gy irradiation. Fig. 1 E is a representative plot from an experiment where 16 Ϯ 9% ( n ϭ 5) of cells were PD-1+ and CFSE-low, whereas 1.4 Ϯ 0.2% ( n ϭ 5) of cells were PD-1+ CFSE-high, at day 32. Because PD-1 is reported to regulate the expansion of self-reactive autoimmune T cells, we also tested the fate of transgenic HY male antigen-specifi c donor cells in a T cell KO environment ( Fig. 1 F ) . Spleen CD8 T cells from female HY-transgenic mice contain ‫ف‬ 30% of cells expressing both the ␣ and ␤ TCR transgenes, whereas the rest represent a diverse T cell population expressing diff erent TCR ␣ proteins. In this and a second experiment, transferred transgenic HY CD8ϩ T cells dramatically expanded by day 6 in male T cell KO mice (3.8 Ϯ 2 ϫ 10 5 , n ϭ 4) in comparison to those in female KO mice (1.9 Ϯ 1.4 ϫ 10 4 , n ϭ 3) or lymphocyte-replete B6 male mice (2.3 Ϯ 0.89 ϫ 10 4 , n ϭ 4) which peripheral tolerance mechanisms are involved in the regulation of T cells responding to self-or environmental antigens during homeostatic reconstitution.
Acute homeostatic proliferation involves the division of T cells with diff erent histories of antigenic exposure. The fate of bona fi de antigen-specifi c memory cells, i.e., those cells that have undergone the full diff erentiation program after encountering a foreign antigen, diff ers from other memory-like cells undergoing acute homeostatic proliferation and expressing memory cell antigens. Our laboratory has shown that lymphocytic choriomeningitis virus (LCMV) -and Pichinde virus -specifi c CD8ϩ memory T cells of no fewer than seven specifi cities are relatively poor at undergoing acute homeostatic proliferation and become substantially reduced in frequency in comparison to other cells responding to a lymphopenic environment ( 1 ) . We show that a molecule that distinguishes between the slowly dividing Ly6Cϩ bona fi de memory cells and the rapidly dividing Ly6C Ϫ memory-like cells is programmed death-1 (PD-1).
PD-1 is a costimulatory molecule originally isolated by subtractive hybridization in a cell death -induced T cell line ( 14 ) . PD-1 is a member of the CD28 gene family and is expressed on activated T, B, and myeloid cells. PD-1 has two known ligands, PD-1 ligand-1 (PD-L1) and PD-L2, which both belong to the B7 superfamily. PD-L1 is expressed on many cell types, such as T, B, dendritic, endothelial, and tumor cells. In contrast, PD-L2 is narrowly expressed on APCs ( 15 ) . The cytoplasmic domain of PD-1 contains an immunoreceptor tyrosine-based inhibitory motif, which can recruit the phosphatase SHP-2 after ligand engagement and inhibit TCR signaling ( 15 ) . This inhibitory function of PD-1 can occur during autoimmunity, allergy, allograft rejection, antitumor immunity, and chronic virus infection, leading to dysfunctional T cells ( 16 -18 ) . C57BL/6 PD-1 Ϫ / Ϫ mice develop a lupus-like syndrome, whereas BALB/c PD-1 Ϫ / Ϫ mice have dilated cardiomyopathy, which is caused by autoantibodies against cardiac troponin I ( 19 -21 ). Moreover, a single nucleotide polymorphism of PD-1 is associated with higher incidences of systemic lupus erythematosus, type 1 diabetes, and rheumatoid arthritis in humans ( 22 -24 ) . These fi ndings suggest that PD-1 plays an important role to negatively regulate immune responses.
We show that PD-1 is expressed on a large subset of acute homeostatically proliferating (HP) cells isolated from lymphopenic environments. These PD-1ϩ HP cells undergo oligoclonal expansion, are dysfunctional, react with the apoptosis indicator Annexin V, and then disappear, suggesting PD-1 involvement in the elimination of autoreactive CD8ϩ T cells and the prevention of autoimmunity. (E) Naive B6 mice were irradiated with 600 Gy. The day after irradiation, spleen leukocytes were isolated from Ly5.1-LCMV -immune mice, labeled with CFSE, and adoptively transferred into irradiated or unirradiated B6 mice. On day 32, leukocytes were harvested from irradiated B6 or unirradiated B6 mice and stained with anti-CD8, -Ly5.1, and -PD-1 antibodies. Gated CD8+ Ly5.1+ donor cells were analyzed for CFSE versus PD-1 intensity. (F) Spleen leukocytes were isolated from HY female mice, labeled with CFSE, and adoptively transferred into T cell KO or normal male or female B6 mice. On day 6, leukocytes were harvested are stained with anti-CD8, -HY TCR, and -PD-1 antibodies. Gated CD8+HY+ donor cells were analyzed for CFSE versus PD-1 intensity. This is representative of two similar experiments.
transgenic CD8ϩ T cells did not lose CSFE, and few expressed PD-1. In contrast, only 6.8 Ϯ 7.8% ( n ϭ 4) of nontransgenic donor cells from HY mice expressed PD-1 on the CFSE-low cell population 6 d after transfer into T cell KO or female mice (2.2 Ϯ 1.8 ϫ 10 4 , n ϭ 3). The expression of PD-1 on the CSFE-low HY cells in the T cell KO male mice was elevated on Ͼ 70% of the cells ( Fig. 1 F , gated on the transgenic cells). In female mice, the transferred HY Figure 2 . Ly6C distinguishes bona fi de memory HP cells from PD-1؉ HP cells. Spleen leukocytes were isolated from Ly5.1-LCMV -immune mice, and before or after adoptive transfer into T cell KO, leukocytes were stimulated with the indicated peptides and stained for surface antigens and intracellular IFN ␥ . The LCMV-specifi c memory T cells were identifi ed by CD44 (A) or Ly6C (B) and IFN ␥ costaining before or after adoptive transfer into T cell KO mice. (C) At day 21, splenocytes from T cell KO or B6 mice were harvested and stained with anti-CD8, -Ly5.1, -Ly6C, and -PD-1 antibodies, revealing three distinct cell populations. This is representative of three similar experiments with three to fi ve mice per group. (D) Spleen leukocytes were isolated from Ly5.1-LCMV -immune mice, and adoptively transferred into irradiated or unirradiated B6 mice. At day 32, splenocytes were harvested and stained with anti-CD8, -Ly5.1, -Ly6C, and -PD-1 antibodies, revealing three distinct cell populations. This plot is of one representative mouse out of fi ve mice.
Ly6C Ϫ ( n ϭ 5), and 30 Ϯ 8% PD-1 Ϫ Ly6Cϩ ( n ϭ 5), with the fi rst two subsets contained mostly within the rapidly dividing CSFE-low population, and the last subset containing virtually all of the slowly dividing bona fi de memory cells. Donor cells transferred into WT C57BL/6 mice remained PD-1 Ϫ and contained Ly6Cϩ and Ly6C Ϫ subsets ( Fig. 2 C ) . Similar results were seen when irradiated mice were used as hosts. Fig. 2 D compares PD-1 to Ly6C expression and shows that 12 Ϯ 8% ( n ϭ 5) of cells are PD-1ϩLy6C Ϫ HP cells, 25 Ϯ 5% ( n ϭ 5) are PD-1 Ϫ Ly6C Ϫ HP cells, and 60 Ϯ 8% ( n ϭ 5) are PD-1 Ϫ Ly6Cϩ HP cells at day 32 in reconstituted irradiated C57BL/6 mice. We questioned whether these three subpopulations had other unique properties that distinguished them from each other.
Expression of activation molecules and growth factor receptors on the three HP subtypes
To characterize the three major populations distinguished by PD-1 and Ly6C costaining, we examined changes in expression of the activation markers CD43 and CD62L. CD43 is normally expressed on all CD8ϩ T cells, but a unique glycosylated form, detected by mAb 1B11, is expressed on activated T cells. 21 d after transfer, 79 Ϯ 2% ( n ϭ 4) of the PD-1ϩLy6C Ϫ HP cells and 34 Ϯ 12% ( n ϭ 4) of the mice (unpublished data). These results suggest that self-reactive cells rapidly divide in a lymphopenic environment and express PD-1.
PD-1؉ HP cells belong to the Ly6C − population
Bona fi de memory CD8ϩ T cells express high levels of CD44 and Ly6C on their cell surface ( 25, 26 ) . Fig. 2 A shows that most HP cells expressed CD44ϩ during homeostatic proliferation, so that molecule is not useful for diff erentiating bona fi de memory cells from memory-like HP cells ( Fig.  2 A ) . This experiment also confi rms that virus-specifi c memory cells are diluted after homeostatic proliferation ( 1 ). In contrast, the overall percentage of Ly6C+ CD8 T cells was similar before and after homeostatic proliferation, and virtually all of the LCMV-specifi c bona fi de memory cells were in this subset ( Fig. 2 B ) . This result suggested that Ly6C might be a good marker to distinguish bona fi de memory cells from at least some of the memory-like HP cells. We next addressed whether Ly6C was expressed on PD-1ϩ CD8 cells 21 d after transfer, which is when PD-1 expression was at its peak. As shown in Fig. 2 C , PD-1 ϩ cells were nearly exclusively located within the Ly6C Ϫ population. Thus, by using PD-1 and Ly6C costaining, we could defi ne three major populations: 45 Ϯ 16% PD-1ϩLy6C Ϫ ( n ϭ 5), 24 Ϯ 8% PD-1 Ϫ population contained most of the Annexin Vϩ cells (MFI ϭ 3,553 Ϯ 320, n ϭ 5), and the other two subsets had few Annexin Vϩ cells (PD-1 Ϫ Ly6C Ϫ HP cells, MFI ϭ 1,246 Ϯ 86, n ϭ 5; PD-1 − Ly6Cϩ HP cells, MFI ϭ 1,054 Ϯ 126, n ϭ 5; Fig. 4 A ) . Many of the PD-1ϩ HP cells expressed low levels of IL-7R ␣ ( Fig. 3 ) , and -7 is an important survival factor of T cells and acts to maintain the expression level of survival PD-1 − Ly6C Ϫ HP cells had elevated glycosylated CD43 expression ( Fig. 3 A ) . However, only 14 Ϯ 8% ( n ϭ 4) of the Ly6C+ HP cells had high levels of glycosylated CD43, suggesting that they were in a lower state of activation ( Fig. 3 A ) . Naive and most memory spleen CD8ϩ T cells generally express high levels of CD62L, but CD62L is down-regulated on activated T cells ( 25, 26 ) . On day 21, expression of CD62L was down-regulated on 90 Ϯ 2% ( n ϭ 4) of the PD-1ϩ Ly6C Ϫ HP cells and 62 Ϯ 5% ( n ϭ 4) of the PD-1 Ϫ Ly6C Ϫ HP cells, but only on 36 Ϯ 6% ( n ϭ 4) of the Ly6Cϩ HP cells ( Fig. 3 B ) . These data suggest that the PD-1ϩ population was highly activated; that the Ly6Cϩ population was mostly resting, despite undergoing some limited division; and that the PD-1 Ϫ Ly6C Ϫ population may be in some intermediate state. This is consistent with the concept that the PD-1+ population may be undergoing the greatest degree of homeostatic proliferation.
Previous studies have demonstrated that IL-7 or -7/-15 plays an important role in homeostatic expansion of naive or memory CD8ϩ T cells ( 27, 28 ) , so we analyzed whether the expression levels of IL-7R ␣ (CD127) and -15R ␤ (CD122) correlated with the proliferation status of the three major populations. As shown in 
Most PD-1؉ cells react with Annexin V؉
In other systems of T cell activation, the down-regulation of IL-7R ␣ expression correlates with reduced viability and impending apoptosis ( 29, 30 ) . Many of the PD-1ϩ cells were low in IL-7R ␣ expression and did not express the high levels of IL-15R ␤ that might be needed to compensate for that loss. We thus questioned whether the PD-1ϩ HP cells, despite their high levels of activation and proliferation, might be a population with a propensity for cell death. To address whether cell death was involved in the progression of homeostatic proliferation, CD8+ donor cells were stained with Annexin V 21 d after transfer. The CFSE-low populations were 36 Ϯ 10% Annexin V+ cells ( n = 7), but the CSFE high population had only 2.4 Ϯ 1% Annexin V+ cells ( n = 7; not depicted), suggesting that high levels of apoptosis might accompany homeostatic proliferation. When the three subpopulations were analyzed for reactivity with Annexin V, the PD-1ϩ HP that this apoptotic cell population declines over time; as 29 Ϯ 11% ( n ϭ 12) of the HP cells were PD-1+Annexin V+ at day 21, decreasing to 17 Ϯ 6% ( n ϭ 6) at day 35, and then to 3 Ϯ 2% ( n ϭ 8) at day 70, when there were very few remaining PD-1ϩ cells. These results demonstrated that PD-1 expression correlated with the Annexin Vϩ preapoptotic state and the presumed elimination of a cell population during homeostatic proliferation.
Defi cient cytokine production by the PD-1؉ HP cells
Previous studies have shown that cytokine production can be inhibited in virus-specifi c PD-1ϩ CD8ϩ T cells during chronic viral infection, and that interference with PD-1 signaling can restore the cytokine production in exhausted CD8+ T cells ( 32 -34 ) . We found that in the CSFE-low populations 21 d molecules such as Bcl-2 ( 31 ) . Fig. 4 A shows that PD1ϩLy6C Ϫ and PD-1 Ϫ Ly6C Ϫ HP cell populations both expressed low levels of Bcl-2 (PD-1ϩLy6C Ϫ HP cells, MFI ϭ 17.2 Ϯ 6.9, n ϭ 3; PD-1 Ϫ Ly6C − HP cells, MFI ϭ 17.2 Ϯ 5.2, n ϭ 3). In contrast, the Ly6Cϩ HP cells, which contained the bona fi de memory cells, expressed much higher levels of Bcl-2 (MFI ϭ 51.1 Ϯ 20.6, n ϭ 3). The bottom row of Fig. 4 compares this to the binding of Annexin V (MFI ϭ 746 Ϯ 56, n ϭ 2) and the expression of Bcl-2 (MFI ϭ 24.5 Ϯ 0.4, n ϭ 2) on total transferred CD8ϩ cells in WT C57BL/6 21 d after transfer. Fig. 4 B shows that 61% of gated PD-1ϩ HP cells stained with Annexin Vϩ at day 21 (comparing PD-1ϩ/ Annexin Vϩ and PD-1ϩ/Annexin V Ϫ populations), suggesting that most of the PD-1ϩ HP cells were in a preapoptotic state 21 d after homeostatic proliferation. Fig. 4 B shows eff ect of the anti -PD-L1 antibody. Thus, the anti -PD-L1 treatment seems to restore cytokine production by PD-1ϩ cells. Similar results were seen in the HY transgenic T cell system, where 7.5 Ϯ 1.2% ( n ϭ 4) of the PD-1ϩ HY cells derived from 6-d transferred T cell KO mice produced IFN ␥ after HY male peptide stimulation in vitro, in contrast to 16 Ϯ 4.9% ( n ϭ 4) of the PD-1 Ϫ HY cells (not depicted). These results with HP cells are consistent with published work in other systems on the inhibitory properties of these molecules ( 32, 33, 35 ) .
Having shown that interference with PD-1 signaling enhances IFN ␥ production in vitro, we tested whether interference with PD-1 signaling in vivo would lead to an increase in the number of CD8 T cells. Suffi cient quantities of antibody to PD-1 were available to us, but we needed to test different timing regimens and doses to establish an eff ect. We found that giving day 20 -23 T cell KO mice (reconstituted with LCMV-immune splenocytes) 2 i. 
Bona fi de memory transgenic T cells are PD-1 ؊ Annexin V ؊ and can produce IFN ␥ during acute homeostatic proliferation
We have interpreted our failure to find LCMV-specific memory CD8 T cells in the PD-1ϩ population to indicate that bona fi de memory cells do not fall into this population. However, we used peptide-induced IFN ␥ production to monitor LCMV-specifi c T cells, and Fig. 5 shows that the PD-1ϩ population is functionally defective in regards to after transfer, 20 Ϯ 6% ( n ϭ 10) of the cells produced IFN ␥ and 12 Ϯ 6% ( n ϭ 7) produced TNF ␣ after anti-CD3 stimulation, suggesting that some memory-like cells have the capacity to make cytokines while undergoing acute homeostatic proliferation (not depicted). Experiments designed to examine the functional capacity of PD-1ϩ cells showed, on average, that only 13 Ϯ 4% ( n ϭ 4) of the PD-1ϩ cells produced IFN ␥ after anti-CD3 stimulation, in contrast to 32 Ϯ 3% ( n ϭ 4) of the PD-1 − HP cells ( Fig. 5 A ) . Similarly, only 4 Ϯ 1% ( n ϭ 3) of the PD-1ϩ HP cells produced TNF ␣ , whereas 21 Ϯ 8% ( n ϭ 3) of PD-1 Ϫ HP cells produced TNF ␣ ( Fig. 5 B ) . Those PD-1ϩ cells that did produce cytokines had lower levels per cell than did the PD-1 Ϫ cells ( Fig. 5, A and B ) .
Because the bona fi de memory cells in the Ly6C+ PD-1 Ϫ population may have biased the results by being the major contributors to cytokine production, we also compared the production of IFN ␥ and TNF ␣ in the Ly6C Ϫ population, separated into PD-1ϩ or PD-1 Ϫ cells. Only 10 Ϯ 1.1% ( n ϭ 4) of PD-1ϩLy6C Ϫ cells produced IFN ␥ after anti-CD3 stimulation, in contrast to 37 Ϯ 1.8% ( n ϭ 4) of the PD-1 Ϫ Ly6C Ϫ cells (not depicted). Similarly, only 4.1 Ϯ 2.5% ( n ϭ 3) of the PD-1ϩLy6C Ϫ cells produced TNF ␣ , in contrast to 40 Ϯ 7.2% ( n ϭ 3) of the PD-1 Ϫ Ly6C Ϫ cells. The abilities of these three fractions to synthesize IFN ␥ or TNF ␣ after anti-CD3 stimulation are summarized in Table I .
We next tested whether the expression of PD-1 may be a cause of the T cell dysfunction by incorporating 25 g/ml anti -PD-L1 mAb into cultures of day 14 HP cells for 3 d. The frequencies of PD-1ϩ cells producing IFN ␥ were signifi cantly enhanced in the presence of anti -PD-L1 mAb (No antibody treatment, 6.6 Ϯ 2.5%, n ϭ 9; anti -PD-L1 mAb treatment, 9.3 Ϯ 2.2%, n ϭ 9; P ϭ 0.03; Fig. 5 C ) , whereas the percentage of PD-1 Ϫ IFN ␥ -producing cells was not signifi cantly changed (No antibody treatment, 16 Ϯ 5.5%, n ϭ 9; anti -PD-L1 mAb treatment, 15 Ϯ 5.4%, n ϭ 9; P ϭ 0.6; Fig.  5 C ) , suggesting that the anti -PD-L1 blocking mAb only affected PD-1 Ϫ expressing cells. Of note is that there was hardly any IFN ␥ production by the highest expressing PD-1ϩ cells, but anti -PD-L1 mAb enabled some of these high-expressing cells to make IFN ␥ ( Fig. 5 C ) . Because it was possible that the high-expressing PD-1ϩ cells that made IFN ␥ had been derived from a PD-1 Ϫ population within the culture, we sorted out CD8ϩPD-1ϩ cells from the ex vivo cell populations before putting them into culture. P14-transgenic memory CD8 T cells were mostly Annexin V Ϫ during homeostatic proliferation, in contrast to some of the nontransgenic Ly5.2+ CD8+ donor cells within the same population ( Fig. 6 B ) . In addition, Fig. 6 C shows that 96% of the P14-transgenic memory CD8 T cells produced IFN ␥ after GP-33 peptide stimulation. These results indicate that bona fi de memory CD8 cells remain functional and do not express PD-1 under conditions of acute homeostatic proliferation.
PD-1+ HP cells undergo oligoclonal expansion
Previous studies have demonstrated that PD-1 becomes expressed on T cells that are repeatedly and strongly stimulated through their TCR ( 36, 37 ) . Consistent with those fi ndings, the PD-1ϩ HP cells observed here had a highly activated phenotype, suggesting frequent stimulation through their TCR ( Fig. 3 ) . We questioned whether this strong stimulation would select for specifi c T cell clones outcompeting other clones. To address this question, we used all available V ␤ monoclonal antibodies (V ␤ 2-14) to investigate the TCR V ␤ repertoires at day 21. V ␤ staining of the total HP population revealed polyclonal populations with moderate TCR skewing, so we analyzed the three subpopulations of HP cells defi ned by PD-1 and Ly6C. As shown in Fig. 7 A , considerable TCR V ␤ skewing was seen in the PD-1ϩ population, indicating oligoclonal patterns of expansion, and there was great variation among mice regarding the V ␤ usage of the skewed population. This high variation between mice was unusual, given that mice 1 -5 and 6 -8 received the same pooled donor cells, respectively. This may indicate that the progenitors for these oligoclonal expansions were of very low frequency in the donor populations. The skewed oligoclonal expansions were almost exclusively within the PD-1ϩ subset of the Ly6C Ϫ cells, as Fig. 7 A shows little skewing of TCR in either the PD-1 Ϫ Ly6C Ϫ or in the PD-1 Ϫ Ly6Cϩ populations, which remained polyclonal. The polyclonal V ␤ profi les of those populations seemed very similar to the V ␤ profi les of CD8 T cells from LCMV-immune mice used as donors ( Fig. 7 B ) . Thus, the oligoclonal expansions, which are indicative of highly proliferating T cell populations, were exclusively within the PD-1ϩ cell populations. These results, along with those in Fig. 4 , suggest that discrete clones of donor nonmemory T cells might interact with endogenous antigens with suffi ciently high affi nity such that they dramatically expand, are induced to express PD-1, and then become apoptotic and disappear under these conditions of acute homeostatic proliferation. An alternative hypothesis, however, is that the oligoclonally expanded cells lost their PD-1 expression but remained in the host. To test for this, we examined the TCR ␤ usage in the Ly6C Ϫ and Ly6Cϩ cells 70 d after transfer, after the PD-1ϩ cells had virtually disappeared ( Fig. 7 C ) . At this time point, no TCR skewing in either HP fraction was seen, and the two fractions looked nearly identical. Further, of the 8 tested T cell populations from day 21 displayed in Fig. 7 A , expanded V ␤ populations could be easily seen in nonsubdivided donor CD8 T cell populations from all but mouse 6, which had a relatively low (27%) frequency of PD-1ϩ cells cytokine production. By these criteria we cannot rule out the presence of dysfunctional bona fi de memory cells within the PD-1ϩ population. It is diffi cult to get convincing tetramer staining of these low frequencies of memory CD8 T cells under these conditions of acute homeostatic proliferation, so we did analyses using P14 transgenic memory CD8 T cells, which can be identifi ed by anti-V ␣ 2 and -V ␤ 8.1/8.2 staining. We generated P14-transgenic memory CD8 T cells in C57BL/6 mice, as described in the Materials and methods, and then adoptively transferred the memory T cell -containing splenocytes into T cell KO mice to address this question. As shown in Fig. 6 A , 94% of the P14-transgenic memory CD8 T cells remained negative for expression of PD-1 in T cell KO or C57BL/6 hosts 20 d after transfer. Furthermore, CD8ϩ T cells, which were mostly expressing PD-1, had dramat ically decreased by 54 d after transfer, in comparison to the HY cell numbers 6 d after transfer (day 6, 5.5 Ϯ 0.65 ϫ 10 5 , n ϭ 2; day 54, 5.8 Ϯ 0.47 ϫ 10 4 , n ϭ 2). This strongly argues that those cells have been eliminated from the host, which is consistent with the Annexin Vϩ phenotype of the PD-1ϩ cells when they were present ( Fig. 4 ) .
DISCUSSION
The expression of PD-1 is induced after TCR engagement, and PD-1 is known to down-regulate immune responses to (not depicted). Expansions of a single defi ned V ␤ population representing 30 -42% of the total CD8 T cells were observed in mice 3 -5, 7, and 8. In contrast, expanded V ␤ populations of Ͼ 23% were not found in any of the 6 tested nonsubdivided day 70 populations (individual samples not depicted). Given that Fig. 1 D shows that between day 21 and 70 there is only a modest increase in total CD8 T cell number that would not substantially dilute out the oligoclonal populations, we interpret these data to indicate that the expanded oligoclonal populations have been drastically reduced in frequency by day 70. We also found that the number of transferred HY transgenic lymphopenic environment and stays expressed as they divide within that environment. Fig. 2 shows that virtually all of the bona fi de memory cells were Ly6Cϩ, but it is not clear whether all Ly6Cϩ cells originated as bona fi de memory cells. Nevertheless, the phenotype is remarkably diff erent from that of the other subsets. Despite the fact that these cells are dividing, albeit slowly, they do not have an activation antigen phenotype. In addition, they function normally in regard to cytokine production on TCR stimulation, which is best illustrated with the transgenic P14-transgenic memory CD8 T cells, where 96% produced IFN ␥ after stimulation ( Fig. 6 ) . The Ly6Cϩ HP cells express high levels of growth factor receptors, high levels of Bcl-2, and are viable, as indicated by their lack of reactivity with Annexin V. This population shows no indication of oligoclonal expansion.
The PD-1ϩ oligoclonally expanding cell population appears to be eventually lost ( Fig. 7 ) , and the bona fi de memory cell population, staining with Ly6C and dividing slowly, is gradually diluted. Although virtually all of the bona fi de memory cells expressed Ly6C, this does not mean that all Ly6Cϩ cells are bona fi de memory cells and that Ly6Cϩ can be a marker to reliably distinguish bona fi de memory cells from other HP cells, and it is possible that some Ly6C Ϫ HP cells might eventually convert to expressing the Ly6C marker. The day 21 PD-1 Ϫ Ly6C Ϫ subset, however, has its own unique phenotype in that, while actively dividing, it has no evidence of oligoclonal expansion, suggesting that it consists of cells not reacting with high affi nity to self-or endogenous antigens. Although expressing low levels of Bcl-2, these cells are functional and viable, in that they make cytokines on anti-CD3 stimulation and fail to react with Annexin V. Bcl-2 is sometimes down-regulated in activated dividing cells without being associated with apoptosis ( 31 ) . Down-regulation of IL-7R ␣ is frequently correlated with a preapoptotic state, but no such down-regulation was seen in this population.
Thus, it would seem that acute homeostatic proliferation selects against those cells that are reacting strongly to either self-antigens or other endogenous antigens, such as those expressed by microbial fl ora. These cells initially expand oligoclonally, and but then undergo apoptosis, as the immune system is gradually repopulated with a less vigorously expanding polyclonal population.
MATERIALS AND METHODS
Mice. C57BL/6 male mice (Ly5.2ϩ) were purchased from The Jackson Laboratory and used at 8 -12 wk of age. B6.SJL (Ly5.1ϩ) mice, which are congenic to C57BL/6 mice, except for the Ly5.1 marker, were purchased from Taconic Farms at 4 -5 wk of age. P14 TCR (Ly5.1ϩ) transgenic mice (expressing transgenic TCR specifi c for the D b -restricted LCMV epitope GP33 -41) ( 39 ), B6.129P2 Tcrbtml Mom Tcrdtml Mom ( ␣ ␤ ␥ ␦ KO) mice (T cell-KO) ( 40 ) , and C57BL/6 HY-transgenic mice, whose transgenic TCR is specifi c for the H-2D b -restricted male antigen HY ( 41, 42 ) , were bred within the Department of Animal Medicine at the University of Massachusetts Medical School. All of these mice were maintained in accordance with the guidelines of the Institutional Animal Care and Use Committee of the University of Massachusetts Medical School and age-and sex-matched before use.
self-antigens or pathogens ( 16 ) . We found that HP cell populations present during acute homeostatic proliferation could be divided into the following three subsets defi ned by expression of PD-1 and Ly6C: PD-1ϩLy6C Ϫ , PD-1 Ϫ Ly6C Ϫ , and PD-1 Ϫ Ly6Cϩ. The properties of these HP subsets are summarized in Table I . The PD-1ϩ population was mostly devoid of bona fi de memory cells, consisted of dramatically expanded distinct oligoclonal V ␤ populations, and expressed a highly activated antigenic phenotype. The PD-1ϩ cells had reduced growth factor receptor expression, low Bcl-2, and presented with a preapoptotic phenotype, as shown by their reactivity with Annexin V. These cells were in a dysfunctional state, as they produced cytokines poorly on anti-CD3 stimulation. T cells that react with Annexin V can remain viable for some time and, in contrast to those found here, continue to secrete cytokines. For example, most Annexin Vϩ CD8 T cells present during acute LCMV infection maintain their ability to produce cytokines ( 29, 38 ) . Even though Annexin V reactivity can be a property of actively dividing and still functioning T cells, studies have shown that those Annexin Vϩ T cells are far more susceptible to death than Annexin V Ϫ cells, when placed into in vitro culture or transferred in vivo ( 32, 38 ) . PD-1ϩ CD8 cells during persistent LCMV infection, where they receive repeated signaling through their TCR, have a similar phenotype to these PD-1ϩ HP cells in that they fail to produce cytokines on TCR stimulation; treatment of mice with anti -PD-L1 can restore their functional phenotype ( 32 -34 ) . We show in our model of acute homeostatic proliferation that anti -PD-L1 can enhance IFN ␥ production by the PD-1ϩ cells in vitro, and that anti -PD-1 can increase the number of total and IFN ␥ -producing CD8 T cells in vivo, arguing for an important functional role for PD-1 in this system.
The ultimate fate of these highly active oligoclonally expanded PD-1+ HP cells during acute homeostatic proliferation appears to be elimination from the host, as most of them disappear by 70 d after transfer. We interpret this to mean that those cells that are most self-reactive or reactive with other endogenous ligands initially undergo dramatic oligoclonal proliferation, express PD-1, become functionally inactive, and are eliminated from the host. This is consistent with previous observations that PD-1 KO mice spontaneously develop autoimmune diseases and suggests an important role for PD-1 under conditions of lymphopenia.
The properties of the PD-1ϩ T cell subset diff ered dramatically from the other subsets ( Table I ) . Naive T cells are induced to express CD44 during acute homeostatic proliferation ( 5, 6 ), but we have reported that bona fi de CD44ϩ antigen-specifi c memory cells, which have undergone the full diff erentiation series as a consequence of the immune response, only divide at a modest level and are diluted during acute homeostatic proliferation ( 1 ) . Because of similarities in CD44 expression, it has been diffi cult to distinguish memory cells from memory-like cells during this process. We show that Ly6C may be useful for this process. It is expressed on virtually all bona fi de memory cells before transfer into the 
